Gilead Sciences, Inc.
HBV VACCINES AND METHODS TREATING HBV

Last updated:

Abstract:

Provided are HBV immunogenic polypeptides, polynucleotides encoding such polypeptides, vectors expressing such immunogenic polypeptides for use in eliciting an immune response against HBV; pharmaceutical and immunogenic compositions and kits comprising such polypeptides, polynucleotides or vectors, and methods of use in treating and/or preventing HBV.

Status:
Application
Type:

Utility

Filling date:

28 Sep 2020

Issue date:

1 Apr 2021